Elevance Health (ELV) Operating Expenses (2009 - 2026)

Elevance Health (ELV) has 18 years of Operating Expenses data on file, last reported at $47.9 billion in Q1 2026.

• Quarterly Operating Expenses rose 3.87% year-over-year to $47.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $194.2 billion (up 10.61% YoY) and the FY2025 annual result came in at $192.4 billion, up 13.78% from the prior year.
• Operating Expenses slipped to $47.9 billion in Q1 2026 per ELV's latest filing, from $49.5 billion in the prior quarter.
• Across five years, Operating Expenses topped out at $49.5 billion in Q4 2025 and bottomed at $35.8 billion in Q1 2022.
• The 5-year median for Operating Expenses is $41.2 billion (2023), against an average of $42.5 billion.
• The widest annual swing landed in 2022, when Operating Expenses rose 18.47%; it then decreased 0.8% in 2024.
• Tracing ELV's Operating Expenses over 5 years: stood at $38.9 billion in 2022, then gained by 7.1% to $41.6 billion in 2023, then grew by 7.66% to $44.8 billion in 2024, then climbed by 10.47% to $49.5 billion in 2025, then dropped by 3.34% to $47.9 billion in 2026.
• Per Business Quant, the three latest ELV Operating Expenses figures stand at $47.9 billion (Q1 2026), $49.5 billion (Q4 2025), and $49.3 billion (Q3 2025).

Peer Comparison